Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
17371 | 539 | 33.9 | 65% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
261 | 18876 | PROTEIN C//ACTIVATED PROTEIN C//TISSUE FACTOR |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | SECT HEPATOBILIARY SURG LIVER TRANSPLANTAT | Address | 4 | 19% | 3% | 17 |
2 | AMINO ACIDS THERAPEUTIC USE | Author keyword | 2 | 67% | 0% | 2 |
3 | LIVER DISEASES COMPLICATIONS | Author keyword | 2 | 50% | 1% | 3 |
4 | HEMOSTATIC ABNORMALITIES | Author keyword | 2 | 43% | 1% | 3 |
5 | HEPATOSPLENIC SCHISTOSOMIASIS | Author keyword | 2 | 23% | 1% | 6 |
6 | BLOOD COAGULATION DISORDERS ETIOLOGY THERAPY | Author keyword | 1 | 100% | 0% | 2 |
7 | PROTAC R | Author keyword | 1 | 50% | 0% | 2 |
8 | HYPERFIBRINOLYSIS | Author keyword | 1 | 13% | 1% | 8 |
9 | HUME LEE TRANSPLANT | Address | 1 | 16% | 1% | 5 |
10 | GASTROENTEROL 3 | Address | 1 | 23% | 1% | 3 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | ACCELERATED FIBRINOLYSIS | 48 | 91% | 4% | 20 |
2 | INCREASED PLASMA FIBRINOLYSIS | 22 | 68% | 4% | 19 |
3 | CONVENTIONAL COAGULATION TESTS | 11 | 48% | 3% | 16 |
4 | DEFECTIVE AGGREGATION | 5 | 63% | 1% | 5 |
5 | CIRRHOSIS PATIENTS | 4 | 31% | 2% | 11 |
6 | ABNORMAL HEMOSTASIS TESTS | 3 | 57% | 1% | 4 |
7 | COMPENSATED FORM | 3 | 100% | 1% | 3 |
8 | HOSPITALIZED CIRRHOSIS PATIENTS | 3 | 100% | 1% | 3 |
9 | HYPERFIBRINOLYSIS | 3 | 19% | 3% | 15 |
10 | THROMBIN ACTIVATABLE FIBRINOLYSIS | 2 | 14% | 2% | 12 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
MECHANISMS OF DISEASE The Coagulopathy of Chronic Liver Disease | 2011 | 219 | 61 | 36% |
The coagulation system in patients with end-stage liver disease | 2015 | 2 | 31 | 39% |
Deep vein thrombosis and pulmonary embolism in cirrhotic patients: Systematic review | 2014 | 4 | 52 | 67% |
Efficacy and safety of the use of heparin as thromboprophylaxis in patients with liver cirrhosis: A systematic review and meta-analysis | 2013 | 6 | 15 | 73% |
Hemostasis in Liver Disease: Implications of New Concepts for Perioperative Management | 2014 | 8 | 99 | 30% |
Abnormalities of hemostasis in chronic liver disease: Reappraisal of their clinical significance and need for clinical and laboratory research | 2007 | 65 | 43 | 42% |
Coagulopathy in liver diseases | 2010 | 23 | 35 | 51% |
Hypercoagulability in cirrhosis: causes and consequences | 2011 | 65 | 96 | 36% |
Established and new-generation antithrombotic drugs in patients with cirrhosis - Possibilities and caveats | 2013 | 11 | 58 | 28% |
Clinical utility of viscoelastic tests of coagulation in patients with liver disease | 2013 | 9 | 104 | 31% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | SECT HEPATOBILIARY SURG LIVER TRANSPLANTAT | 4 | 19% | 3.2% | 17 |
2 | HUME LEE TRANSPLANT | 1 | 16% | 0.9% | 5 |
3 | GASTROENTEROL 3 | 1 | 23% | 0.6% | 3 |
4 | COURSE POLYCLIN THER Y | 1 | 50% | 0.2% | 1 |
5 | DIGEST HLTH EXCELLENCE GI HEPATOL | 1 | 50% | 0.2% | 1 |
6 | GASTROENTEROL GI SURG | 1 | 50% | 0.2% | 1 |
7 | GUVEN HOSP | 1 | 50% | 0.2% | 1 |
8 | HEMATOL ONCOLWARREN ALPERT MED | 1 | 50% | 0.2% | 1 |
9 | IRCCSMAGGIORE HOSP | 1 | 50% | 0.2% | 1 |
10 | LIVER UNITHEPAT HAEMODYNAM | 1 | 50% | 0.2% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000196929 | POSTREPERFUSION SYNDROME//POST REPERFUSION SYNDROME//VENO VENOUS BYPASS |
2 | 0.0000174536 | CLIN PATHOL BIOCHEM//ALPHA2 ANTIPLASMIN//TC 99M NC100668 |
3 | 0.0000121045 | PORTAL VEIN THROMBOSIS//PORTAL BILIOPATHY//REX SHUNT |
4 | 0.0000098347 | DESMOPRESSIN//DDAVP//PHARMACOLOGY DESMOPRESSIN |
5 | 0.0000089438 | ACTIVATED PARTIAL THROMBOPLASTIN TIMES//BLUMEA RIPARIA//INTRATHECAL FIBRINOLYSIS |
6 | 0.0000086750 | THROMBIN GENERATION//SYN SE BV//PHYS BIOCHEM BLOOD |
7 | 0.0000083768 | TAFI//CARBOXYPEPTIDASE U//THROMBIN ACTIVATABLE FIBRINOLYSIS INHIBITOR |
8 | 0.0000083481 | RFVIIA//RECOMBINANT ACTIVATED FACTOR VII//RECOMBINANT FACTOR VIIA |
9 | 0.0000080730 | PERITONEOVENOUS SHUNT//DENVER SHUNT//MALIGNANT ASCITES |
10 | 0.0000070915 | PROTHROMBIN COMPLEX CONCENTRATE//PROTHROMBIN COMPLEX CONCENTRATES//ANTICOAGULATION REVERSAL |